Trial Information

Summary: Active Crohn's Disease: International, Multicenter, Double-Blind, Placebo-controlled study for moderate to severe Crohn's Disease.

Study Description

Screening period of 7-10 days

• Physical examination, laboratory tests & Chest X-ray
• Daily diary
• Questionnaire

Treatment period of 10 weeks

• Monthly infusions
• 5 Study visits (3 infusions & 3 office visits)

Follow-up phase

• 12, 20 & 32 week visits
• Potential candidate for long term study

• 18 years of age or older
• History of Crohn's Disease for at least 6 months confirmed radiological or endoscopic confirmation
• Stable low dose prednisolone (or equivalent)

• Oral prednisolone (or equivalent) exceeding 25 mg/day
• Use of anti-TNF therapy in the last 90 days
• Use of herbal preparations during therapy
• Subject with colostomy, ileostomy or short bowel syndrome

If you would like to learn more about participating in this study, please send an e-mail message using the form below.